Skip to main content
logo
Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
1.930
-0.060 (-3.02%)
At close: Aug 14, 2026, 4:00 PM EDT
2.060
+0.130 (6.74%)
After-hours: Aug 14, 2026, 7:55 PM EDT

Alaunos Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-4.11-4.18-4.68-35.14-37.73-78.75
Depreciation & Amortization
0.020.0102.322.762.6
Other Amortization
---1.340.980.38
Loss (Gain) From Sale of Assets
---0.010.01-
Asset Writedown & Restructuring Costs
---4.8-0.74
Stock-Based Compensation
0.490.410.442.83.5310.77
Other Operating Activities
0.410.41--0.010.35-0.35
Change in Accounts Receivable
00-001.113.56
Change in Accounts Payable
-0.430.1-0.1-0.77-0.030.27
Change in Other Net Operating Assets
0.490.37-0.63-5.48-0.21-0.69
Operating Cash Flow
-3.13-2.87-4.97-30.14-29.23-61.47
Operating Cash Flow Growth
------
Capital Expenditures
-0.1-0.1--0.2-0.22-3.32
Sale of Property, Plant & Equipment
---1.540.02-
Investing Cash Flow
-0.1-0.1-1.35-0.19-3.32
Long-Term Debt Issued
-----25
Long-Term Debt Repaid
----18.23-8.33-
Net Debt Issued (Repaid)
----18.23-8.3325
Issuance of Common Stock
1.911.91-0.0914.751.04
Repurchase of Common Stock
-----0.05-
Other Financing Activities
------0.26
Financing Cash Flow
3.263.26--18.146.3725.78
Net Cash Flow
0.040.29-4.97-46.93-23.06-39.02
Free Cash Flow
-3.23-2.97-4.97-30.34-29.45-64.79
Free Cash Flow Growth
------
Free Cash Flow Margin
-107533.33%-59340.00%-49710.00%-606780.00%-1007.80%-16279.15%
Free Cash Flow Per Share
-1.58-1.52-3.10-18.97-20.34-45.33
Levered Free Cash Flow
-2.14-0.75-3.3-5.1-27.95-33.39
Unlevered Free Cash Flow
-2.14-0.75-3.3-5.24-26.96-33.03
Cash Interest Paid
---2.062.170.63
Change in Working Capital
0.070.47-0.73-6.250.873.14
SEC Filings: 10-K · 10-Q